While the reasons behind the observed sex differences on the pattern of GLP-1R β-arrestin 2 dependency have not been analyzed here in detail, note that current existing data suggest reduced effectiveness of GLP-1RA treatments for T2D and weight loss in males, while females display instead a higher propensity for adverse side effects to incretin treatment (45). The gene discussed is GCG; the disease is type 2 diabetes mellitus.